Publications by authors named "Nasreen Abdul Aziz"

Claim this Profile
S
Systematic Review and Meta-Analysis of the Management of Relapsed Germ Cell Tumours Following Cisplatin-Based Chemotherapy.
Nasreen Abdul Aziz, Didjier Danger Masangwi, Pinky Kotecha, Gustavo Loback, Kenrick Ng

Oncol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Impact of Low-Grade Toxicities to Adjuvant Pembrolizumab in Stage III Melanoma.
Nasreen Abdul Aziz, David Burke, Waleed Khalifa, Sharanniyan Ragavan, Ruth Board

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment de-escalation for metastatic good-risk seminoma with carboplatin AUC10: predictive factors and patterns of relapse.
Nasreen Abdul Aziz, Didjier Danger Masangwi, Sushila Ganguli, Anand Sharma, Kenrick Ng

Ther Adv Med Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours.
Nasreen Abdul Aziz, Kenrick Ng, Constantine Alifrangis, Ben Tran, Ciara Conduit

BJUI Compass· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Real-World Impact of Low-Grade Toxicities to Adjuvant Pembrolizumab in Stage III Melanoma.
Nasreen Abdul Aziz, David Burke, Waleed Khalifa, Sharanniyan Ragavan, Ruth Board

JCO Oncol Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis